610
The potential development of SJS/TEN, a severe life-threatening illness, emphasizes the need for judicious use of TMP-Sx and close monitoring and follow-up for patients who were given TMP-Sx for SSTIs.
 patients: Subject; SJS/TEN, a severe life-threatening illness: Effect; TMP-Sx: Treatment; SSTIs: Treatment.Disorder; TMP: Treatment.Drug; Sx: Treatment.Drug; TMP: Combination.Drug; Sx: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients: Subject; SJS/TEN, a severe life-threatening illness: Effect; TMP-Sx: Treatment; SSTIs: Treatment.Disorder; TMP: Treatment.Drug; Sx: Treatment.Drug; TMP: Combination.Drug; Sx: Combination.Drug